Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications

Completed

Conditions studied: Infertility

In brief

To identify adverse effects of ovulation drugs on pregnancy, including pregnancy loss, fetal teratology and dysmorphology, and infant development up to age 3.

Key facts

Study ID

NCT00902382

Run by

Yale University

People needed

264

Starts

2009-05-01

Expected to finish

2014-06-27

Last updated by the study team

2018-02-07

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Positive serum hCG within the context of a RMN trial;
• History of infertility meeting female subject entry criteria for a RMN trial;
• Informed consent.

You may not qualify if…

• Unable to comply with the demands of the trial.

Where it is running

• University of Alabama Birmingham — Birmingham, Alabama, United States
• Stanford University Medical Center — Stanford, California, United States
• University of Colorado — Aurora, Colorado, United States
• Yale University — New Haven, Connecticut, United States
• University of Michigan — Ann Arbor, Michigan, United States
• Wayne State University — Detroit, Michigan, United States
• Hackensack University — Hackensack, New Jersey, United States
• Carolinas Medical Center — Charlotte, North Carolina, United States
• University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States
• Pennsylvania State University College of Medicine — Hershey, Pennsylvania, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• University of Texas Health Science Center at San Antonio — San Antonio, Texas, United States
• University of Vermont — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.